基于生理学的药代动力学模型
药代动力学
药品
临床药理学
药理学
计算机科学
计算生物学
医学
管理科学
医学物理学
工程类
生物
作者
Ping Zhao,L. Zhang,Joseph A. Grillo,Q. Liu,Julie Bullock,Young Jin Moon,Pengfei Song,Satjit Brar,Rajanikanth Madabushi,Ta C. Wu,Brian Booth,Nam Atiqur Rahman,Kellie S. Reynolds,Eva Gil Berglund,L. J. Lesko,Shiew‐Mei Huang
标识
DOI:10.1038/clpt.2010.298
摘要
Physiologically based pharmacokinetic (PBPK) modeling and simulation is a tool that can help predict the pharmacokinetics of drugs in humans and evaluate the effects of intrinsic (e.g., organ dysfunction, age, genetics) and extrinsic (e.g., drug-drug interactions) factors, alone or in combinations, on drug exposure. The use of this tool is increasing at all stages of the drug development process. This report reviews recent instances of the use of PBPK in decision-making during regulatory review. The examples are based on Center for Drug Evaluation and Research reviews of several submissions for investigational new drugs (INDs) and new drug applications (NDAs) received between July 2008 and June 2010. The use of PBPK modeling and simulation facilitated the following types of decisions: the need to conduct specific clinical pharmacology studies, specific study designs, and appropriate labeling language. The report also discusses the challenges encountered when PBPK modeling and simulation were used in these cases and recommends approaches to facilitating full utilization of this tool.
科研通智能强力驱动
Strongly Powered by AbleSci AI